相关实验视频

Updated: Jul 27, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

瘤生成的活性氧物种风暴用于高性能铁灭疗法

Lin Huang¹, Jiaoyang Zhu¹, Wei Xiong²

¹School of Biomedical Engineering, Southern Medical University, 1023 Sha-Tai South Road, Baiyun, Guangzhou, Guangdong 510515, China.

|June 7, 2023

概括

这项研究介绍了一个纳米平台,可以产生反应性氧物种 (ROS) 风暴,用于增强性铁灭菌疗法 (FT). 该系统克服了瘤微环境的限制,提高了癌症治疗效率.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
癌症治疗癌症治疗

背景情况:

铁灭疗法 (FT) 的有效性受到低顿剂度,不足的过氧化 (H2O2) 和瘤微环境 (TME) 的酸度差的限制.
在TME中过度表达的谷氨 (GSH) 清除反应性氧物种 (ROS),进一步降低FT的性能.

研究的目的:

开发一种对TME有反应的纳米平台,用于产生ROS风暴,以增强瘤中的铁灭疗法 (FT).
为了克服低顿剂度,有限的H2O2和TME中不足的酸度的局限性,用于改进FT.

主要方法:

一个纳米平台 (TAF-HMON-CuP@PPDG) 被设计为在TME启动的降解后释放塔莫西芬 (TAF) 和过氧化铜 (CuP).
释放的TAF会使瘤细胞酸化,促进CuP反应产生H2O2和Cu离子.
铜离子和H2O2之间的循环Fenton类反应产生ROS风暴,而TAF诱导的酸化加速了这一过程,GSH消耗减少了GPX4的表达.

主要成果:

该纳米平台成功地在瘤细胞内产生了ROS风暴.
在癌细胞和瘤携带小鼠中证明了高性能铁灭疗法.
该战略有效地解决了TME的局限性,提高了ROS生成和FT有效性.

结论:

开发的纳米平台有效地触发了ROS风暴,用于高性能铁灭疗法.
这种方法克服了与TME相关的挑战,为癌症治疗提供了一个有希望的策略.
由TME启动的ROS生成显示了改善瘤治疗结果的显著潜力.

关键词:

T1加权的磁共振成像技术对比剂对比剂是一种对比剂.铁化疗法是一种铁化疗法.反应性氧气物种风暴风暴.瘤微环境是一个微环境.

更多相关视频

Author Spotlight: High-Throughput Measurement of Intracellular ROS Levels in Hepatocellular Lines

Author Spotlight: High-Throughput Measurement of Intracellular ROS Levels in Hepatocellular Lines

Published on: January 19, 2024

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Published on: August 6, 2021

相关概念视频

Necrosis

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...